14.41
Inmode Ltd stock is traded at $14.41, with a volume of 311.47K.
It is down -0.41% in the last 24 hours and up +5.18% over the past month.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
See More
Previous Close:
$14.47
Open:
$14.46
24h Volume:
311.47K
Relative Volume:
0.31
Market Cap:
$913.00M
Revenue:
$370.50M
Net Income/Loss:
$93.83M
P/E Ratio:
9.9634
EPS:
1.4463
Net Cash Flow:
$89.39M
1W Performance:
+0.07%
1M Performance:
+5.18%
6M Performance:
-2.44%
1Y Performance:
-1.97%
Inmode Ltd Stock (INMD) Company Profile
Compare INMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
INMD
Inmode Ltd
|
14.41 | 913.00M | 370.50M | 93.83M | 89.39M | 1.4463 |
|
ABT
Abbott Laboratories
|
89.46 | 155.82B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
294.73 | 112.88B | 25.27B | 3.34B | 4.57B | 8.6358 |
|
MDT
Medtronic Plc
|
80.00 | 102.71B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
56.50 | 83.97B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
83.98 | 48.42B | 6.30B | 1.07B | 1.34B | 1.8406 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-29-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-28-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-17-24 | Initiated | BTIG Research | Buy |
| Jul-23-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-03-23 | Downgrade | UBS | Buy → Neutral |
| Oct-13-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-29-23 | Initiated | UBS | Buy |
| Feb-17-23 | Downgrade | Needham | Buy → Hold |
| Dec-21-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| May-18-21 | Initiated | Needham | Buy |
| Sep-03-19 | Initiated | Barclays | Overweight |
| Sep-03-19 | Initiated | Canaccord Genuity | Buy |
| Sep-03-19 | Initiated | Robert W. Baird | Outperform |
| Sep-03-19 | Initiated | UBS | Buy |
View All
Inmode Ltd Stock (INMD) Latest News
Price-Driven Insight from (INMD) for Rule-Based Strategy - Stock Traders Daily
InMode slips after cautious 2026 outlook outweighs Q4 beat - MSN
InMode (INMD) to Release Earnings on Wednesday - MarketBeat
Did Reaffirmed 2026 Revenue Guidance Just Shift InMode's (INMD) Investment Narrative? - simplywall.st
InMode gains on report it's in talks to be acquired by foreign investment fund - msn.com
Inmode gains on report Steel Partners made offer for majority stake - MSN
Assessing InMode (INMD) Valuation After Reaffirmed 2026 Revenue Guidance - Yahoo Finance
InMode wins case against DHGate sellers over counterfeit products - MSN
InMode (INMD) Stock: Direction Change Signals | InMode Ltd Ordinary Shares reports 8% EPS surpriseRecovery Report - Cổng thông tin điện tử tỉnh Lào Cai
INMD (InMode Ltd. Ordinary Shares) Q4 2025 EPS surpasses analyst forecasts, shares rise 2.23 percent on positive investor sentiment.CEO Statement - Cổng thông tin điện tử tỉnh Tây Ninh
InMode (NASDAQ:INMD) Stock Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
(INMD) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
INMD Stock Price, Quote & Chart | INMODE LTD (NASDAQ:INMD) - ChartMill
InMode (INMD) Stock Institutional Buying (Slight Uptick) 2026-04-20High Beta Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
InMode Ltd. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
InMode (INMD) Stock Credit Default (+2.23%) 2026-04-18Social Trade Signals - Cổng thông tin điện tử Tỉnh Sơn La
Michael J Anghel Net Worth (2026) - GuruFocus
InMode Ltd. (INMD) Stock Analysis: Unveiling an 18.63% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Michael Howard Dennison Net Worth (2026) - GuruFocus
Yair Malca Net Worth (2026) - GuruFocus
InMode Ltd. Experiences Evaluation Revision Amidst Challenging Market Dynamics - Markets Mojo
CCORF Maintains InMode(INMD.US) With Hold Rating, Maintains Target Price $15 - Moomoo
InMode: The Beauty Of A Value Trap (NASDAQ:INMD) - Seeking Alpha
InMode Flags Slow Aesthetic Demand, Picofy-Driven Q1 Lift and Margin Pressure at Needham Conference - MarketBeat
InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M - The Malaysian Reserve
InMode Ltd. (NASDAQ:INMD) Rating Update Draws Nasdaq Today Attention - Kalkine Media
Press Release: InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M - Moomoo
Needham Maintains InMode(INMD.US) With Hold Rating - Moomoo
(INMD) InMode Expects 2026 Revenue Range $365M$375M, vs. FactSet Est of $369.6M - marketscreener.com
InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M – Company AnnouncementFT.com - Financial Times
InMode Ltd. (NASDAQ:INMD) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
(INMD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Market Catalysts: Is InMode Ltd a top pick in the sector2026 Volatility Report & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Michael Kreindel Discloses Investment in InMode with 5.11% Stake - TradingView
Insider Moshe Mizrahy boosts InMode (NASDAQ: INMD) stake to 7.06% amid buybacks - Stock Titan
InMode (INMD) CTO Michael Kreindel discloses 5.11% beneficial stake via 13D - Stock Titan
InMode expects Q1 sales below estimates - MSN
Movement Recap: Whats the RSI of InMode Ltd stock2026 Dividend Review & Daily Oversold Bounce Ideas - baoquankhu1.vn
Layoff Watch: Is InMode Ltd stock a good pick for beginnersWeekly Market Outlook & Verified Short-Term Plans - baoquankhu1.vn
Hedge Fund Moves: Can InMode Ltd deliver consistent dividends2026 Volume & AI Enhanced Trading Alerts - baoquankhu1.vn
INMD SEC FilingsInmode Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
InMode Ltd. (INMD) Stock Analysis: Unveiling a 23% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
InMode Ltd. (INMD) stock price, news, quote and history - Yahoo Finance UK
InMode Ltd Stock: Innovative Aesthetic Devices Driving Growth in a Competitive Medical Tech Landscap - AD HOC NEWS
InMode Ltd. Experiences Revision in Stock Evaluation Amid Market Volatility and Performance Challenges - Markets Mojo
Recap Report: Will InMode Ltd outperform tech stocks2026 Bull vs Bear & Weekly High Conviction Trade Ideas - baoquankhu1.vn
JPMorgan Chase & Co. Has $9.61 Million Stake in InMode Ltd. $INMD - MarketBeat
InMode Ltd. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Inmode Ltd Stock (INMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):